{
  "object_id": "revive:tadalafil-2-5mg",
  "object_type": "Dose Decision Object",
  "schema_version": "1.0",
  "language": "en",
  "canonical_url": "/tadalafil-2-5mg/",
  "canonical_page_h1": "Tadalafil 2.5mg: ED Dose Decision Guide",
  "entity_slug": "tadalafil-2-5mg",
  "primary_entity": "tadalafil",
  "entity_family": "ED / PDE5",
  "page_kind": "dose",
  "decision_stage": "BOFU / decision",
  "ymyl": true,
  "source_phase": "Phase 2 Answer-First Citation Blocks",
  "decision_dimensions": [
    "dose_role",
    "effectiveness",
    "response",
    "tolerability",
    "escalation",
    "deescalation",
    "monitoring",
    "interactions",
    "comorbidity",
    "adherence",
    "switching",
    "comparison",
    "safety",
    "patient_context",
    "natural_language",
    "summary"
  ],
  "answers": [
    {
      "query_id": "RZQ-02281",
      "question": "What does tadalafil 2.5 mg mean in the drug's overall dosing range?",
      "short_answer": "Tadalafil 2.5 mg should be interpreted within the regimen being used. Tadalafil can appear in erectile-dysfunction treatment with different timing patterns, so the same drug name does not automatically mean the same practical decision. Tadalafil is often chosen partly because its duration profile differs from shorter-acting PDE5 options.",
      "citations": [
        {
          "label": "MedlinePlus drug information: Tadalafil",
          "url": "https://medlineplus.gov/druginfo/meds/a604008.html"
        },
        {
          "label": "DailyMed current human drug-label search: Tadalafil",
          "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=tadalafil"
        },
        {
          "label": "Clinical guideline context: European Association of Urology: Erectile Dysfunction Guideline",
          "url": "https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/management-of-erectile-dysfunction"
        }
      ]
    },
    {
      "query_id": "RZQ-02282",
      "question": "Why might tadalafil 2.5 mg be chosen instead of a lower or higher strength?",
      "short_answer": "A lower tadalafil strength used regularly answers a different treatment question from a higher as-needed strength. Comparing the milligrams without considering the regimen can therefore be misleading. The page should stay focused on how 2.5 mg is actually being used.",
      "citations": [
        {
          "label": "MedlinePlus drug information: Tadalafil",
          "url": "https://medlineplus.gov/druginfo/meds/a604008.html"
        },
        {
          "label": "DailyMed current human drug-label search: Tadalafil",
          "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=tadalafil"
        },
        {
          "label": "Clinical guideline context: European Association of Urology: Erectile Dysfunction Guideline",
          "url": "https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/management-of-erectile-dysfunction"
        }
      ]
    },
    {
      "query_id": "RZQ-02283",
      "question": "Is tadalafil 2.5 mg usually a starting, middle, or upper-range dose decision?",
      "short_answer": "Tadalafil 2.5 mg should be interpreted within the regimen being used. Tadalafil can appear in erectile-dysfunction treatment with different timing patterns, so the same drug name does not automatically mean the same practical decision. Tadalafil is often chosen partly because its duration profile differs from shorter-acting PDE5 options.",
      "citations": [
        {
          "label": "MedlinePlus drug information: Tadalafil",
          "url": "https://medlineplus.gov/druginfo/meds/a604008.html"
        },
        {
          "label": "DailyMed current human drug-label search: Tadalafil",
          "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=tadalafil"
        },
        {
          "label": "Clinical guideline context: European Association of Urology: Erectile Dysfunction Guideline",
          "url": "https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/management-of-erectile-dysfunction"
        }
      ]
    }
  ],
  "related_questions": [
    {
      "query_id": "RZQ-02281",
      "question": "What does tadalafil 2.5 mg mean in the drug's overall dosing range?",
      "priority": "P1",
      "micro_intent": "dose_role"
    },
    {
      "query_id": "RZQ-02282",
      "question": "Why might tadalafil 2.5 mg be chosen instead of a lower or higher strength?",
      "priority": "P1",
      "micro_intent": "dose_role"
    },
    {
      "query_id": "RZQ-02283",
      "question": "Is tadalafil 2.5 mg usually a starting, middle, or upper-range dose decision?",
      "priority": "P1",
      "micro_intent": "dose_role"
    },
    {
      "query_id": "RZQ-02284",
      "question": "What should someone expect to evaluate after using tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "effectiveness"
    },
    {
      "query_id": "RZQ-02285",
      "question": "If tadalafil 2.5 mg is not working well enough, does that automatically mean the dose should be increased?",
      "priority": "P2",
      "micro_intent": "response"
    },
    {
      "query_id": "RZQ-02286",
      "question": "How can someone tell whether tadalafil 2.5 mg is doing what it is supposed to do?",
      "priority": "P2",
      "micro_intent": "response"
    },
    {
      "query_id": "RZQ-02287",
      "question": "What side effects would make tadalafil 2.5 mg worth reviewing?",
      "priority": "P2",
      "micro_intent": "tolerability"
    },
    {
      "query_id": "RZQ-02288",
      "question": "When can a lower dose than tadalafil 2.5 mg become a reasonable discussion?",
      "priority": "P2",
      "micro_intent": "tolerability"
    },
    {
      "query_id": "RZQ-02289",
      "question": "What evidence would justify moving above tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "escalation"
    },
    {
      "query_id": "RZQ-02290",
      "question": "What evidence would justify stepping down from tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "deescalation"
    },
    {
      "query_id": "RZQ-02291",
      "question": "What monitoring matters after starting or changing to tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "monitoring"
    },
    {
      "query_id": "RZQ-02292",
      "question": "Can other medicines change how tadalafil 2.5 mg should be evaluated?",
      "priority": "P2",
      "micro_intent": "interactions"
    },
    {
      "query_id": "RZQ-02293",
      "question": "How can kidney, liver, heart, or vascular conditions affect the decision around tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "comorbidity"
    },
    {
      "query_id": "RZQ-02294",
      "question": "Could timing or missed doses make tadalafil 2.5 mg look ineffective?",
      "priority": "P2",
      "micro_intent": "adherence"
    },
    {
      "query_id": "RZQ-02295",
      "question": "When should someone consider changing the drug instead of changing tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "switching"
    },
    {
      "query_id": "RZQ-02296",
      "question": "How is tadalafil 2.5 mg different from the nearest lower strength?",
      "priority": "P2",
      "micro_intent": "comparison"
    },
    {
      "query_id": "RZQ-02297",
      "question": "How is tadalafil 2.5 mg different from the nearest higher strength?",
      "priority": "P2",
      "micro_intent": "comparison"
    },
    {
      "query_id": "RZQ-02298",
      "question": "What are the main safety questions to ask before changing tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "safety"
    },
    {
      "query_id": "RZQ-02299",
      "question": "What if tadalafil 2.5 mg works but causes side effects?",
      "priority": "P2",
      "micro_intent": "patient_context"
    },
    {
      "query_id": "RZQ-02300",
      "question": "What if tadalafil 2.5 mg is tolerated but the treatment goal is not reached?",
      "priority": "P2",
      "micro_intent": "patient_context"
    },
    {
      "query_id": "RZQ-02301",
      "question": "I am taking tadalafil 2.5 mg. What should I track before asking for a dose change?",
      "priority": "P2",
      "micro_intent": "natural_language"
    },
    {
      "query_id": "RZQ-02302",
      "question": "My doctor mentioned tadalafil 2.5 mg. What questions should I ask before changing doses?",
      "priority": "P2",
      "micro_intent": "natural_language"
    },
    {
      "query_id": "RZQ-02303",
      "question": "How do I know whether the problem is the dose or the medication itself with tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "natural_language"
    },
    {
      "query_id": "RZQ-02304",
      "question": "What is the most important decision logic around tadalafil 2.5 mg?",
      "priority": "P2",
      "micro_intent": "summary"
    }
  ],
  "evidence": [
    {
      "label": "MedlinePlus drug information: Tadalafil",
      "url": "https://medlineplus.gov/druginfo/meds/a604008.html"
    },
    {
      "label": "DailyMed current human drug-label search: Tadalafil",
      "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=tadalafil"
    },
    {
      "label": "Clinical guideline context: European Association of Urology: Erectile Dysfunction Guideline",
      "url": "https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/management-of-erectile-dysfunction"
    }
  ],
  "review": {
    "visible_page_review_date": null,
    "object_generated_date": "2026-09-11",
    "claim_level_confidence": "not_assigned",
    "confidence_note": "This object preserves answer text and citations already present on the canonical page. Claim-level confidence scoring and source-provenance grading are deferred to the later evidence/provenance phase."
  },
  "safety": {
    "educational_only": true,
    "not_individual_prescribing_advice": true,
    "do_not_stop_or_change_prescription_without_clinician_review": true
  },
  "implementation": {
    "preferred_rendering": "answer-first blocks + machine-readable JSON",
    "new_url_required": false,
    "canonical_page_remains_primary": true
  }
}